[PDF] Top 20 Immunoregulatory T Cell Function in Multiple Myeloma
Has 10000 "Immunoregulatory T Cell Function in Multiple Myeloma" found on our website. Below are the top 20 most common "Immunoregulatory T Cell Function in Multiple Myeloma".
Immunoregulatory T Cell Function in Multiple Myeloma
... Multiple myeloma is a malignancy characterized by uncontrolled monoclonal B cell differentiation and immunoglobulin ...B cell differentiation assays, proliferation and polyclonal ... See full document
12
State of Oral Mucosa as an Additional Symptom in the Course of Primary Amyloidosis and Multiple Myeloma Disease
... stem cell transplantation is supposed to allow safe administration of big doses of chemotherapy, thus increasing the chances of ...the multiple myeloma remains to a great extent an incurable disease, ... See full document
6
Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independent
... regulatory cell types, focus has shifted towards cellular mediated tumour-induced immune suppression and ...regulatory T-cells have now been identified including naturally occurring T Reg cells (nT ... See full document
10
<p>Selective purging of human multiple myeloma cells from peripheral blood mononuclear cells: a preliminary study</p>
... multiple myeloma. The purging process to remove contaminating residual myeloma cells could improve patient out- ...human multiple myeloma cells from peripheral blood mononuclear cells ... See full document
5
CAR-T “the living drugs”, immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy
... bispecific T cell engagers, and antibody- drug conjugates make the antibody-directed agents more powerful with less ...for T cells have led to the revolution of modern cancer ...immunotherapy. ... See full document
5
A patient with Multiple myeloma and Renal cell carcinoma
... Sehgal reported a rare case of metastatic prostatic cancer to bone marrow and MM as secondary malignancy. He suggested that probably bone marrow microenvironment play a crucial role in the development of myeloma. ... See full document
5
B Cell Differentiation and Immunoregulatory T Cell Function in Human Cord Blood Lymphocytes
... of T and B lymphocyte populations from human newborns was evaluated using a reverse hemolytic plaque assay to detect immunoglobulin-secreting cells generated in in vitro cultures stimulated with pokeweed mitogen ... See full document
7
B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma
... tumor-specific T cells, including CAR T cells, in humans has most commonly followed some form of lymphodepleting conditioning (13, 14, 24–26), which has been demonstrated to enhance T ... See full document
13
FIFTEEN YEARS OF SINGLE CENTER EXPERIENCE WITH STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA: A RETROSPECTIVE ANALYSIS
... Multiple myeloma is the second most frequent hemato- logic malignancy responsible for about 86,000 new cases worldwide each year ...large, multiple myeloma is still considered to be incurable ... See full document
5
Original Article Zoledronic acid inhibits cell growth of multiple myeloma cells and shows synergistic anti-myeloma effects with Bortezomib via downregulation of pim-2 through NF-κB pathway
... RPMI-8226 cell line was treated with ZOL alone at various concentra- tions and combined with Bortezomib in vitro, then Cell proliferation, cell apoptosis, downstream signaling pathway were detected ... See full document
9
Potent Induction of Apoptosis by β-Lapachone in Human Multiple Myeloma Cell Lines and Patient Cells
... -Lapachone was investigated as a novel and potent DNA repair inhibitor that sensitizes cells to ionizing radiation and DNA damaging agents (10,11). We have reported that it and its derivatives inhibit eukaryotic ... See full document
8
Multiple myeloma presenting as cutaneous leukocytoclastic vasculitis and eosinophilia disclosing a T helper type 1/T helper type 2 imbalance: a case report
... affect myeloma cell growth by the blockade of NF-κB and down-regulation of cytokines, such as IL-6 ...CD8 T cells, and repair T-helper sub- sets with the Th1/Th2 response ...diagnosed ... See full document
6
Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy
... stress response. The anticancer effects of bortezomib as a single agent have been demonstrated in xenograft models of multiple myeloma, adult T-cell leukemia, lung, breast, prostate, ... See full document
9
Increased activated regulatory T cell subsets and aging Treg-like cells in multiple myeloma and monoclonal gammopathy of undetermined significance: a case control study
... mixed T cell cultures were stimulated with anti-CD3/CD28 coated beads (cell: beads = 1:1) (Dyna- beads human T-activator CD3/CD28, Life Technolo- gies, USA) in 96-well plates for 90–96 ... See full document
8
Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T cell mediated immune responses
... ventricular function for Chagas disease patients, where LVEF <55 % and LVDD/ body surface area ≥31 mm were used to define Chagas disease dilated cardiomyopathy ... See full document
11
Immunoregulatory subsets of the T helper and T suppressor cell populations in homosexual men with chronic unexplained lymphadenopathy
... B cell responses, is normally represented in lymphadenopathy ...T4 T cell ...T8 T cells: the T8:TQ1- or T8:Leu-8- subset is elevated, whereas the T8:TQ1+ or T8:Leu-8+ subset is normally ...T4 ... See full document
12
Bone Marrow Mast Cell Density Correlates with Circulating Biomarkers of Bone Disease in Multiple Myeloma
... possess multiple roles: they are accumulated in BM microenvironment as an initial host response, with potential tumorcidial ...means, myeloma cells secrete attractants for MCs, but in turn, they secrete ... See full document
10
Original Article Immunomodulatory effect of DC/CIK combined with chemotherapy in multiple myeloma and the clinical efficacy
... The incidence of MM in China is 2-4 per ten thousand every year, and the middle-aged and the senior make up the most vulnerable popu- lation. MM is only second to non-Hodgkin’s lym- phoma in terms of incidence among all ... See full document
10
Cancer testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma
... One prerequisite for the development of effective can- cer immunotherapies is the identification of appropriate target antigens. Cancer-testis antigens (CTA) are a fam- ily of proteins which show an expression restricted ... See full document
12
Chimeric antigen receptor T cell therapies for multiple myeloma
... Antibody-dependent cell-mediated cytotoxicity; AE: Adverse event; ALL: Acute lymphocytic leukemia; APRIL: A proliferation-inducing ligand; ASCO: American Society Clinical Oncology; ASCT: Autologous stem ... See full document
12
Related subjects